Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-03Phase II Study of Concurrent Tislelizumab and Radiotherapy for Treatment-naïve, Newly Diagnosed Low-risk Extranodal NK/T-cell Lymphoma, Nasal Type
-
CLINICAL_TRIALS study record update · 2024-03-28Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
-
CLINICAL_TRIALS study record update · 2024-03-22HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
-
CLINICAL_TRIALS study record update · 2024-03-22The LYMfit Study: Exercise Training to Prevent Cardiovascular Disease in Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2024-03-19Natural Killer Cell Selected T-cell Depleted Donor Lymphocyte Infusions (NK-DLI) in Patients After HLA-haploidentical Allogeneic Stem Cell Transplantation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-19Prospective, Single-arm, Multicenter Exploratory Clinical Study of the Combination of Etoposide, Cytarabine and PEG-rhG-CSF (EAP Regimen) as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2024-03-08An Open-Label Phase II Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
-
CLINICAL_TRIALS study record update · 2024-03-07An Open-Label, Multicenter Phase 1/1b Study of Intratumorally Administered STING Agonist E7766 in Subjects With Advanced Solid Tumors or Lymphomas - INSTAL-101
-
CLINICAL_TRIALS study record update · 2024-03-06Spa Therapy for Upper or Lower Limb Lymphoedema : a Randomized and Comparative Study
-
CLINICAL_TRIALS study record update · 2024-03-01An Open-label Study of ALPN-202 Combined With PD-1 Inhibition in Subjects With Advanced Malignancies (NEON-2)
-
CLINICAL_TRIALS study record update · 2024-02-29Early Rehabilitation of Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-02-26Phase 1 Open-label, Multicenter Study of MK-1454 Administered by Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab for Patients With Advanced/Metastatic Solid Tumors or Lymphomas
-
CLINICAL_TRIALS study record update · 2024-02-26Phase II, Randomised, Multicentre Study With Two Treatment Arms (R-COMP Versus R-CHOP) in Newly Diagnosed Elderly Patients (≥60 Years) With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb.
-
CLINICAL_TRIALS study record update · 2024-02-23A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection (Anti LAG-3 Monoclonal Antibody) in Patients With Advanced/Metastatic Solid Tumor or Lymphoma
-
CLINICAL_TRIALS study record update · 2024-02-21Musculoskeletal Health in Adult Haematoloigcal Cancer Survivors - a Mixed Methods Study
-
CLINICAL_TRIALS study record update · 2024-02-20Geriatric Communication Skills Training Program for Oncology Clinicians to Improve Management of Care for Geriatrics Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-02-16RAT-HEMATO : Return to Work After Malignant Hemopathy
-
CLINICAL_TRIALS study record update · 2024-02-13Pilot Study on the Reduced Intravenous Fluids to Improve Clearance of High-Dose Methotrexate (HDMTX) in Children With Lymphoma or Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2024-02-01Phase I Clinical Trial of Substance Balance of [14C]SHR2554 in Healthy Chinese Subjects
-
CLINICAL_TRIALS study record update · 2024-01-25A Phase 1/2, Open-label, Multicenter Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Fadraciclib (CYC065), an Oral CDK 2/9 Inhibitor, in Subjects With Advanced Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2024-01-23SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart
-
CLINICAL_TRIALS study record update · 2024-01-19A Phase I, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Glofitamab as Single Agent Administered After a Fixed, Single Dose Pretreatment of Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2024-01-12The Pathogenesis and Prognostic Factors of Lymphoma
-
CLINICAL_TRIALS study record update · 2024-01-12A Comparative Study of Retrospective Outcomes Including Efficacy of Therapy Between Advanced Immunotherapy and Classical Immunochemotherapy in Relapsed/Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2024-01-12A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 1703; Progress III); Companion Study: Microbiome and Immune Reconstitution in Cellular Therapies and Hematopoietic Stem Cell Transplantation (BMT CTN 1801; Mi-Immune)